Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 30, 2011, Pages 3465-3474

  Vieira Brock, Paula L ^a,b   Miller, Eleanor I ^b   Nielsen, Shannon M ^b   Fleckenstein, Annette E ^a   Wilkins, Diana G ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Brain; Liquid chromatography mass spectrometry; Metabolites; Nicotine; Rat

Indexed keywords

ANALYTES; ANALYTICAL METHOD; BRAIN TISSUE; CALIBRATION CURVES; COTININE; EXTRACTION RECOVERY; GRADIENT ELUTION; INTERNAL STANDARDS; LC-MS/MS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MATRIX EFFECTS; MULTIPLE REACTION MONITORING; NICOTINE; OVERALL PROCESS EFFICIENCIES; POSITIVE ELECTROSPRAY IONIZATION; RAT BRAIN; RAT BRAIN TISSUE; SOLID-PHASE EXTRACTION; TARGET ANALYTES; VALIDATED METHODS;

BIOMOLECULES; BRAIN; COLUMN CHROMATOGRAPHY; DEUTERIUM; ELECTROSPRAY IONIZATION; EXTRACTION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; HISTOLOGY; MASS SPECTROMETRY; METABOLISM; METABOLITES; PYRIDINE; QUALITY CONTROL; RATS; TISSUE;

LIQUIDS;

3' HYDROXYCOTININE; ANABASINE; ANATABINE; COTININE; COTININE N BETA DEXTRO GLUCURONIDE; COTININE N OXIDE; NICOTINE; NICOTINE DERIVATIVE; NICOTINE N BETA DEXTRO GLUCURONIDE; NICOTINE N' OXIDE; NORCOTININE; NORNICOTINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; SOLID PHASE EXTRACTION;

ALKALOIDS; ANABASINE; ANIMALS; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; CHROMATOGRAPHY, LIQUID; COTININE; LINEAR MODELS; MALE; NICOTINE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 80555150610     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.09.026     Document Type: Article

References (40)

1. Benowitz N.L. Annu. Rev. Pharmacol. Toxicol. 2009, 49:57.
2. Benowitz N.L. N. Engl. J. Med. 2010, 362:2294.
3. Li C., Schuetz J.D., Naren A.P. Cancer Lett. 2010, 292(2):246.
4. Weems J.M., Yost G.S. Chem. Res. Toxicol. 2010, 23:696.
5. Alexandrov K., Rojas M., Satarug S. Toxicol. Lett. 2010, 198:63.
6. Chiba M., Masironi R. Bull. World Health Org. 1992, 70(2):269.
7. Japuntich S.J., Piper M.E., Leventhal A.M., Bolt D.M., Baker T.B. J. Consult. Clin. Psychol. 2011, 79(1):34.
8. Kralikova E., Kozak J.T., Rasmussen T., Gustavsson G., Le Houezec J. BMC Public Health 2009, 9:433.
9. Bordia T., Campos C., Huang L., Quik M. JPET 2008, 327:239.
10. Huang L., Paramenswaran N., Bordia T., McIntosh M., Quik M. J. Neurochem. 2009, 109:826.
11. Akaike A., Takada-Takatori Y., Kume T., Izumi Y. J. Mol. Neurosci. 2010, 40:211.
12. Buckingham S.D., Jones A.K., Brown L.A., Sattelle D.B. Pharmacol. Rev. 2009, 61:39.
13. Levin E.D., Conners C.K., Silva D., Canu W., March J. Exp. Clin. Psycopharmacol. 2001, 9:83.
14. Quik M., Huang L.Z., Parameswaran N., Bordia T., Campos C., Perez X.A. Biochem. Pharmacol. 2009, 78:677.
15. Vieregge A., Sieberer M., Jacobs H., Hagenah J.M., Vieregge P. Neurology 2001, 57:1032.
16. Villafane G., Cesaro P., Rialland A., Baloul S., Azimi S., Bourdet C., Le Houezec J., Macquin-Mavier I., Maison P. Eur. J. Neurol. 2007, 14:1313.
17. Ebersbach G., Stock M., Muller J., Wenning G., Wissel J., Poewe W. Mov. Disord. 1999, 14:1011.
18. Deutsch J., Hegedus L., Greig N.H., Rapoport S.I., Soncrant T.T. J. Chromatogr. 1992, 579(1):93.
19. Sarasin A., Schlumpf M., Muller M., Fleischmann I., Lauber M.E., Lichtensteiger W. Reprod. Toxicol. 2003, 17:153.
20. Kim K.Y., Lee Y.-J., Chung B.C., Hong J., Jung B.H. Drug Chem. Toxicol. 2010, 33(2):166.
21. Jung B.H., Chung B.C., Chung S.-J., Lee M.-H., Shim C.-K. J. Pharm. Biomed. Anal. 1999, 20:195.
22. Urakawa N., Nagata T., Kudo K., Kimura K., Imamura T. Int. J. Legal Med. 1994, 106:232.
23. Shakleya D.M., Huestis M.A. Anal. Bioanal. Chem. 2009, 393:1957.
24. Miller E.I., Norris H.K., Rollins D.E., Tiffany S.T., Wilkins D.G. J. Chromatogr. B 2010, 878:725.
25. Mwenifumbo J.C., Tyndale R.F. Nicotine Psycopharmacol. Rev. 2009, 192:235.
26. Rossini A., de Almeida Simão T., Albano R.M., Pinto L.F.R. Pharmacogenomics 2008, 9:1737.
27. Ho M.K., Mwenifumbo J.C., Koudsi A.I., Okuyemi K.S., Ahluwalia J.S., Benowitz N.L., Tyndale R.F. Clin. Pharmacol. Ther. 2009, 85(6):635.
28. Dwoskin L.P., Teng L., Buxton S.T., Crooks P.A. JPET 1999, 288:905.
29. Crooks P.A. Chemical properties of nicotine and other tobacco related compounds. Analytical Determination of Nicotine and Related Compounds and Their Metabolites 1999, 69. Elsevier, Oxford. J.W. Gorrod, P. Jacob (Eds.).
30. Crooks P.A., Dwoskin L.P. Biochem. Pharmacol. 1997, 54:743.
31. Teng L., Crooks P.A., Buxton S.T., Dwoskin L.P. JPET 1997, 283:778.
32. Dwoskin L.P., Teng L., Crooks P.A. Eur. J. Pharmacol. 2001, 428:69.
33. Bardo M.T., Green T.A., Crooks P.A., Dwoskin L.P. Psychopharmacology 1999, 146:290.
34. Guo J., Zhou D., Grimm S.W. J. Pharm. Biomed. Anal. 2011, 55:964.
35. Chen G., Giambrone N.E., Dluzen D.F., Muscat J.E., Berg A., Gallagher C.J., Lazarus P. Cancer Res. 2010, 70:7543.
36. Hong S.P., Jeong M.G., Lim D.Y. J. Cardiol. 2007, 50:351.
37. Clemens K.J., Caille S., Stinus L., Cador M. Int. J. Neuropsychopharmacol. 2009, 12:1355.
38. Gosheh O., Dwoskin L.P., Li W.-K., Crooks P.A. Drug Metab. Dispos. 1999, 27:1448.
39. Crooks P.A., Li M., Dwoskin L.P. Drug Metab. Dispos. 1997, 25:47.
40. Rowell P.P., Li M. J. Neurochem. 1997, 68:1982.